In the two years since the Food and Drug Administration approved the first synthetic ketamine treatment, drug developers, VC investors, and rich guys who like Burning Man have been scheming for ways to convert psychedelics from a stoner pastime into a private enterprise.

On Tuesday, New York-based company MindMed will start...